Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208011 · ClinicalTrials.gov registry record
A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes
A clinical trial, sponsored by Louisiana State University, Baton Rouge.
- Completed
- Registry status
- 140
- Enrollment target
NCT02208011: Completed study, sponsored by Louisiana State University, Baton Rouge.
NCT02208011 is a clinical trial that has completed, run by Louisiana State University, Baton Rouge. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02208011 has completed, sponsored by Louisiana State University, Baton Rouge.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart review after delivery. Inclusion Criteria: * English speaking * pregnant woman \>15 weeks gestation undergoing an exam for ruptured membranes Exclusion Criteria: * Known placental previa * Active vaginal bleeding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-06 |
What the finished NCT02208011 record still lists
NCT02208011 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02208011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02208011 about?
NCT02208011 is a clinical study titled "A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes". Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart review after delivery. Inclusion Criteria: * English speaking * pregnant woman \>15 weeks gestation undergoing an exam...
What is the current status of trial NCT02208011?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2014-08. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02208011?
This trial is sponsored by Louisiana State University, Baton Rouge, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia